Quarterly report pursuant to Section 13 or 15(d)

Revenues from Contracts and Significant Customers - Additional Information (Details)

v3.20.2
Revenues from Contracts and Significant Customers - Additional Information (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Revenue from Contract with Customer, Including Assessed Tax $ 9,415,000 $ 8,199,000 $ 21,361,000 $ 14,324,000
3PL Title Model | Revenue | Customer Concentration Risk [Member]        
Concentration risk, percentage   84.00%   86.00%
Company's Dermatology Products Customer        
Concentration risk, percentage       10.00%
Company's Dermatology Products Customer | Customer Concentration Risk [Member]        
Concentration risk, percentage     10.00%  
Accounts Receivable, Net $ 12.4 $ 77.0 $ 12.4 $ 77.0
Company's Dermatology Products Customer | Revenue        
Concentration risk, percentage 10.00%   10.00%